Industry Information

Urokinase Manufacturer provides instructions on Urokinase for injection

  Urokinase is composed of sterile lyophilized purified products (extracted from fresh human urine), human plasma albumin, sodium hydrogen phosphate and sodium dihydrogen phosphate. Therefore, the injectable products are mainly used for thrombolytic therapy of thromboembolic diseases, pulmonary embolism, acute myocardial infarction, ocular inflammation and traumatic tissue edema, etc. So today I want to tell you about the use of this product when some matters needing attention.

Urokinase Manufacturer provides instructions on Urokinase for injection

  1. Before using this product, the patient needs to count hematocrit and platelet, determine thrombin time and prothrombin time, activated part of thrombin activator time and euglobulin dissolution time.

  2. The patient's reaction should be closely observed throughout the medication period, and the patient's pulse rate, body temperature, respiratory rate, blood pressure and bleeding should be noted at least once every four hours. If allergic symptoms such as rash and urticaria are found, the product should be discontinued immediately.

  3. If intravenous administration is required, puncture is required once successfully to avoid local bleeding or hematoma.

  4. When arterial puncture is needed for drug administration, pressure should be applied to the puncture area after injection for at least 30 minutes, and sterile bandages and dressings should be used for pressure dressing to avoid bleeding.

  5. Use this product with caution in patients who delivered within the last 10 days, underwent tissue biopsy, venipuncture, underwent major surgery or severe gastrointestinal bleeding.

  6. Use this product with caution in patients at risk of left heart thrombosis, such as mitral stenosis with atrial fibrillation.

  7. People with subacute bacterial endometritis should use this product with caution.

  8. People who suffer from secondary liver and kidney diseases and have bleeding tendency and coagulation disorder should use this product with caution.

  9. Pregnant women, cerebrovascular patients and diabetic hemorrhagic retinopathy should use this product with caution.

  10. This product should not be diluted with acid solution, so as not to reduce the efficacy.

  About the use of urokinase for injection matters needing attention will be introduced to you here, if you need biological products can be directly contacted, welcome to inquire!